C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yingying YangXiu LiHui QianGuangci DiRuhua ZhouYuwei DongWenyue ChenQingling RenPublished in: Computational intelligence and neuroscience (2022)
CRP may be utilized as a prognostic indicator for a variety of gynecologic malignancies, including cervical cancer, ovarian cancer, endometrial cancer, and vulvar cancer.